Peckham DG - Search Results

1

Noninvasive Ventilation in Cystic Fibrosis: Clinical Indications and Outcomes in a Large UK Adult Cystic Fibrosis Center.

Spoletini G, Pollard K, Watson R, Darby MJ, Johnstone A, Etherington C, Whitaker P, Clifton IJ, Peckham DG. Spoletini G, et al. Among authors: peckham dg. Respir Care. 2021 Mar;66(3):466-474. doi: 10.4187/respcare.07862. Epub 2020 Sep 8. Respir Care. 2021. PMID: 32900912 Free article.

2

Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis.

Baldwin DR, Hill AL, Peckham DG, Knox AJ. Baldwin DR, et al. Among authors: peckham dg. Respir Med. 1994 Jan;88(1):49-53. doi: 10.1016/0954-6111(94)90174-0. Respir Med. 1994. PMID: 8029514 Free article. Clinical Trial.

3

Alcaligenes infection in cystic fibrosis.

Tan K, Conway SP, Brownlee KG, Etherington C, Peckham DG. Tan K, et al. Among authors: peckham dg. Pediatr Pulmonol. 2002 Aug;34(2):101-4. doi: 10.1002/ppul.10143. Pediatr Pulmonol. 2002. PMID: 12112775

4

Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.

Denton M, Rajgopal A, Mooney L, Qureshi A, Kerr KG, Keer V, Pollard K, Peckham DG, Conway SP. Denton M, et al. Among authors: peckham dg. J Hosp Infect. 2003 Nov;55(3):180-3. doi: 10.1016/s0195-6701(03)00299-8. J Hosp Infect. 2003. PMID: 14572484

5

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.

Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J. Li J, et al. J Antimicrob Chemother. 2003 Dec;52(6):987-92. doi: 10.1093/jac/dkg468. Epub 2003 Oct 29. J Antimicrob Chemother. 2003. PMID: 14585859

6

Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.

Conway SP, Brownlee KG, Denton M, Peckham DG. Conway SP, et al. Among authors: peckham dg. Am J Respir Med. 2003;2(4):321-32. doi: 10.1007/BF03256660. Am J Respir Med. 2003. PMID: 14719998 Review.

7

Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.

Saralaya D, Peckham DG, Hulme B, Tobin CM, Denton M, Conway S, Etherington C. Saralaya D, et al. Among authors: peckham dg. J Antimicrob Chemother. 2004 Feb;53(2):325-8. doi: 10.1093/jac/dkh072. Epub 2004 Jan 16. J Antimicrob Chemother. 2004. PMID: 14729733 Clinical Trial.

8

Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.

Conway SP, Etherington C, Peckham DG, Brownlee KG, Whitehead A, Cunliffe H. Conway SP, et al. Among authors: peckham dg. J Antimicrob Chemother. 2004 May;53(5):841-7. doi: 10.1093/jac/dkh175. Epub 2004 Mar 24. J Antimicrob Chemother. 2004. PMID: 15044430 Clinical Trial.

9

Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis.

Peckham D, Watson A, Pollard K, Etherington C, Conway SP. Peckham D, et al. J Cyst Fibros. 2002 Dec;1(4):281-6. doi: 10.1016/s1569-1993(02)00100-5. J Cyst Fibros. 2002. PMID: 15463828 Free article.

10

A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.

Conway SP, Etherington C, Peckham DG, Whitehead A. Conway SP, et al. Among authors: peckham dg. J Cyst Fibros. 2003 Mar;2(1):25-8. doi: 10.1016/S1569-1993(02)00142-X. J Cyst Fibros. 2003. PMID: 15463842 Free article. Clinical Trial.

11

Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?

Etherington C, Peckham DG, Conway SP, Denton M. Etherington C, et al. Among authors: peckham dg. J Cyst Fibros. 2003 Dec;2(4):220-1. doi: 10.1016/S1569-1993(03)00096-1. J Cyst Fibros. 2003. PMID: 15463878 Free article. No abstract available.

12

Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure.

Clifton IJ, Morton AM, Ambrose NS, Peckham DG, Conway SP. Clifton IJ, et al. Among authors: peckham dg. J Cyst Fibros. 2004 Dec;3(4):273-5. doi: 10.1016/j.jcf.2004.06.008. J Cyst Fibros. 2004. PMID: 15698947 Free article.

13

Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.

Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP. Etherington C, et al. Among authors: peckham dg. J Cyst Fibros. 2007 Jan;6(1):67-73. doi: 10.1016/j.jcf.2006.05.013. Epub 2006 Jul 17. J Cyst Fibros. 2007. PMID: 16844430 Free article.

14

An unusual cause of hypercalcaemia in a patient with cystic fibrosis.

Clifton IJ, Morton AM, Peckham DG, Conway SP. Clifton IJ, et al. Among authors: peckham dg. J Cyst Fibros. 2007 Sep;6(5):369-70. doi: 10.1016/j.jcf.2006.12.004. Epub 2007 Jan 30. J Cyst Fibros. 2007. PMID: 17267294 Free article. No abstract available.

15

Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Clifton IJ, Kastelik JA, Peckham DG, Hale A, Denton M, Etherington C, Conway SP. Clifton IJ, et al. Among authors: peckham dg. Epidemiol Infect. 2008 Jan;136(1):128-34. doi: 10.1017/S0950268807008278. Epub 2007 Mar 12. Epidemiol Infect. 2008. PMID: 17352838 Free PMC article.

16

Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case report.

Patel T, Clifton IJ, Kastelik JA, Peckham DG. Patel T, et al. Among authors: peckham dg. J Med Case Rep. 2007 May 3;1:17. doi: 10.1186/1752-1947-1-17. J Med Case Rep. 2007. PMID: 17477864 Free PMC article.

17

Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.

Etherington C, Hall M, Conway S, Peckham D, Denton M. Etherington C, et al. J Antimicrob Chemother. 2008 Feb;61(2):425-7. doi: 10.1093/jac/dkm481. Epub 2007 Dec 21. J Antimicrob Chemother. 2008. PMID: 18156280

18

A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.

Clifton IJ, Fletcher LA, Beggs CB, Denton M, Peckham DG. Clifton IJ, et al. Among authors: peckham dg. BMC Microbiol. 2008 Jun 26;8:105. doi: 10.1186/1471-2180-8-105. BMC Microbiol. 2008. PMID: 18582388 Free PMC article.

19

Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.

White H, Pollard K, Etherington C, Clifton I, Morton AM, Owen D, Conway SP, Peckham DG. White H, et al. Among authors: peckham dg. J Cyst Fibros. 2009 May;8(3):179-85. doi: 10.1016/j.jcf.2008.12.002. J Cyst Fibros. 2009. PMID: 19179122 Free article.

20

Acute Burkholderia cenocepacia pyomyositis in a patient with cystic fibrosis.

El-Laboudi AH, Etherington C, Whitaker P, Clifton IJ, Conway SP, Denton M, Peckham DG. El-Laboudi AH, et al. Among authors: peckham dg. J Cyst Fibros. 2009 Jul;8(4):273-5. doi: 10.1016/j.jcf.2009.04.007. Epub 2009 May 17. J Cyst Fibros. 2009. PMID: 19451037 Free article.

21

A/H1N1 flu pandemic. A/H1N1 and other viruses affecting cystic fibrosis.

Whitaker P, Etherington C, Denton M, Conway S, Peckham D. Whitaker P, et al. BMJ. 2009 Sep 29;339:b3958. doi: 10.1136/bmj.b3958. BMJ. 2009. PMID: 19808817 No abstract available.

22

An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.

Clifton IJ, Fletcher LA, Beggs CB, Denton M, Conway SP, Peckham DG. Clifton IJ, et al. Among authors: peckham dg. J Cyst Fibros. 2010 Jan;9(1):64-8. doi: 10.1016/j.jcf.2009.11.004. Epub 2009 Nov 27. J Cyst Fibros. 2010. PMID: 19944655 Free article.

23

Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.

Lavergne SN, Whitaker P, Peckham D, Conway S, Park BK, Naisbitt DJ. Lavergne SN, et al. Chem Res Toxicol. 2010 Jun 21;23(6):1009-11. doi: 10.1021/tx100151v. Chem Res Toxicol. 2010. PMID: 20481640

24

Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.

Clifton IJ, Peckham DG. Clifton IJ, et al. Among authors: peckham dg. Expert Rev Respir Med. 2010 Aug;4(4):519-29. doi: 10.1586/ers.10.42. Expert Rev Respir Med. 2010. PMID: 20658913 Review.

25

Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers.

Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Daniels T, et al. Chest. 2011 Aug;140(2):425-432. doi: 10.1378/chest.09-3074. Epub 2011 Feb 17. Chest. 2011. PMID: 21330381

26

Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.

Elsheikh A, Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, El-Ghaiesh S, Farrell J, Pichler WJ, Peckham D, Park BK, Naisbitt DJ. Elsheikh A, et al. J Allergy Clin Immunol. 2011 Jun;127(6):1543-51.e3. doi: 10.1016/j.jaci.2010.12.1119. Epub 2011 Feb 26. J Allergy Clin Immunol. 2011. PMID: 21354601

27

Rapid desensitization for non-immediate reactions in patients with cystic fibrosis.

Whitaker P, Shaw N, Gooi J, Etherington C, Conway S, Peckham D. Whitaker P, et al. J Cyst Fibros. 2011 Jul;10(4):282-5. doi: 10.1016/j.jcf.2011.02.002. Epub 2011 Mar 9. J Cyst Fibros. 2011. PMID: 21388896 Free article.

28

Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Whitaker P, Meng X, Lavergne SN, El-Ghaiesh S, Monshi M, Earnshaw C, Peckham D, Gooi J, Conway S, Pirmohamed M, Jenkins RE, Naisbitt DJ, Park BK. Whitaker P, et al. J Immunol. 2011 Jul 1;187(1):200-11. doi: 10.4049/jimmunol.1100647. Epub 2011 May 23. J Immunol. 2011. PMID: 21606251 Free PMC article.

29

Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.

Clifton IJ, Whitaker P, Metcalfe R, Phillip M, Shaw N, Conway SP, Peckham DG. Clifton IJ, et al. Among authors: peckham dg. J Antimicrob Chemother. 2011 Oct;66(10):2438-40. doi: 10.1093/jac/dkr300. Epub 2011 Jul 25. J Antimicrob Chemother. 2011. PMID: 21791443 Clinical Trial. No abstract available.

30

The Effect of Sub-MIC β-Lactam Antibiotic Exposure of Pseudomonas aeruginosa Strains from People with Cystic Fibrosis in a Desiccation Survival Model.

Clifton IJ, Denton M, M'zali F, Peckham DG. Clifton IJ, et al. Among authors: peckham dg. Int J Microbiol. 2011;2011:712618. doi: 10.1155/2011/712618. Epub 2011 Sep 29. Int J Microbiol. 2011. PMID: 21977035 Free PMC article.

31

The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.

Whitaker P, Etherington C, Williams K, Conway S, Peckham D. Whitaker P, et al. J Cyst Fibros. 2012 Jul;11(4):353. doi: 10.1016/j.jcf.2012.01.007. Epub 2012 Feb 16. J Cyst Fibros. 2012. PMID: 22341263 Free article. No abstract available.

32

Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.

El-Ghaiesh S, Monshi MM, Whitaker P, Jenkins R, Meng X, Farrell J, Elsheikh A, Peckham D, French N, Pirmohamed M, Park BK, Naisbitt DJ. El-Ghaiesh S, et al. J Pharmacol Exp Ther. 2012 Jun;341(3):597-610. doi: 10.1124/jpet.111.190900. Epub 2012 Feb 27. J Pharmacol Exp Ther. 2012. PMID: 22371438 Free PMC article.

33

Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Greally P, Whitaker P, Peckham D. Greally P, et al. Curr Med Res Opin. 2012 Jun;28(6):1059-67. doi: 10.1185/03007995.2012.674500. Epub 2012 May 10. Curr Med Res Opin. 2012. PMID: 22401602 Review.

34

Bloodstream infections in cystic fibrosis: nine years of experience in both adults and children.

Cargill J, Etherington C, Peckham D, Conway S, Denton M. Cargill J, et al. J Cyst Fibros. 2012 Jul;11(4):337-9. doi: 10.1016/j.jcf.2012.02.004. Epub 2012 Mar 11. J Cyst Fibros. 2012. PMID: 22414533 Free article.

35

Nonimmediate β-lactam reactions in patients with cystic fibrosis.

Whitaker P, Naisbitt D, Peckham D. Whitaker P, et al. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):369-75. doi: 10.1097/ACI.0b013e328355b849. Curr Opin Allergy Clin Immunol. 2012. PMID: 22729028 Review.

36

Sequential bronchoscopy in the management of lobar atelectasis secondary to allergic bronchopulmonary aspergillosis.

Whitaker P, Brownlee K, Lee T, Conway S, Etherington C, Peckham D. Whitaker P, et al. J Bronchology Interv Pulmonol. 2011 Jan;18(1):57-60. doi: 10.1097/LBR.0b013e318206ea63. J Bronchology Interv Pulmonol. 2011. PMID: 23169021

37

β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.

Jenkins RE, Yaseen FS, Monshi MM, Whitaker P, Meng X, Farrell J, Hamlett J, Sanderson JP, El-Ghaiesh S, Peckham D, Pirmohamed M, Park BK, Naisbitt DJ. Jenkins RE, et al. Chem Res Toxicol. 2013 Jun 17;26(6):963-75. doi: 10.1021/tx400124m. Epub 2013 May 23. Chem Res Toxicol. 2013. PMID: 23668298

38

Myocardial infarction in an adult with cystic fibrosis and heart and lung transplant.

Eaden J, Peckham D. Eaden J, et al. Multidiscip Respir Med. 2013 Jun 7;8(1):37. doi: 10.1186/2049-6958-8-37. Multidiscip Respir Med. 2013. PMID: 23759073 Free PMC article.

39

Drug induced complications; can we do more?

Peckham D, Whitaker P. Peckham D, et al. J Cyst Fibros. 2013 Dec;12(6):547-58. doi: 10.1016/j.jcf.2013.04.014. Epub 2013 Jun 13. J Cyst Fibros. 2013. PMID: 23768657 Free article. Review.

40

Enteral tube feeding in adults with cystic fibrosis; patient choice and impact on long term outcomes.

White H, Morton AM, Conway SP, Peckham DG. White H, et al. Among authors: peckham dg. J Cyst Fibros. 2013 Dec;12(6):616-22. doi: 10.1016/j.jcf.2013.05.003. Epub 2013 Jun 14. J Cyst Fibros. 2013. PMID: 23770301 Free article.

41

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG. Etherington C, et al. Among authors: peckham dg. J Cyst Fibros. 2014 Jan;13(1):49-55. doi: 10.1016/j.jcf.2013.06.004. Epub 2013 Jul 23. J Cyst Fibros. 2014. PMID: 23891398 Free article.

42

Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function.

Gibson A, Ogese M, Sullivan A, Wang E, Saide K, Whitaker P, Peckham D, Faulkner L, Park BK, Naisbitt DJ. Gibson A, et al. J Immunol. 2014 Mar 15;192(6):2611-2621. doi: 10.4049/jimmunol.1302720. Epub 2014 Feb 7. J Immunol. 2014. PMID: 24510967 Free PMC article.

43

The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit.

Peckham D, Etherington C, White H, Mehta A, Shaw N, Morton A, Pollard K, Lee T, Brownlee K, Taylor J, Whitaker P, Conway S. Peckham D, et al. J Cyst Fibros. 2014 Dec;13(6):681-6. doi: 10.1016/j.jcf.2014.03.002. Epub 2014 Mar 23. J Cyst Fibros. 2014. PMID: 24670246 Free article.

44

Reply to Professor Taylor.

Peckham D, Whitaker P. Peckham D, et al. J Cyst Fibros. 2014 Jul;13(4):486-7. doi: 10.1016/j.jcf.2014.03.001. Epub 2014 Apr 18. J Cyst Fibros. 2014. PMID: 24746986 Free article. No abstract available.

45

Research in progress-electronic patient records: a new era.

Peckham D, Whitaker P, White H. Peckham D, et al. Thorax. 2015 May;70(5):473-5. doi: 10.1136/thoraxjnl-2014-206573. Epub 2014 Dec 10. Thorax. 2015. PMID: 25504824 Review.

46

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase.

Ogese MO, Jenkins RE, Maggs JL, Meng X, Whitaker P, Peckham D, Faulkner L, Park BK, Naisbitt DJ. Ogese MO, et al. Chem Res Toxicol. 2015 Jan 20;28(1):144-54. doi: 10.1021/tx500458k. Epub 2015 Jan 7. Chem Res Toxicol. 2015. PMID: 25531135

47

HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.

Ogese MO, Saide K, Faulkner L, Whitaker P, Peckham D, Alfirevic A, Baker DM, Sette A, Pirmohamed M, Park BK, Naisbitt DJ. Ogese MO, et al. Clin Exp Allergy. 2015 Aug;45(8):1305-16. doi: 10.1111/cea.12546. Clin Exp Allergy. 2015. PMID: 25851465

48

Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis.

Shah A, Connelly M, Whitaker P, McIntyre C, Etherington C, Denton M, Hale A, Harvala H, Simmonds P, Peckham DG. Shah A, et al. Among authors: peckham dg. Eur Respir J. 2015 Jun;45(6):1748-51. doi: 10.1183/09031936.00229114. Eur Respir J. 2015. PMID: 25976682 Free article. No abstract available.

49

Fungal contamination of nebuliser devices used by people with cystic fibrosis.

Peckham D, Williams K, Wynne S, Denton M, Pollard K, Barton R. Peckham D, et al. J Cyst Fibros. 2016 Jan;15(1):74-7. doi: 10.1016/j.jcf.2015.06.004. Epub 2015 Jun 20. J Cyst Fibros. 2016. PMID: 26104996 Free article.

50

Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy.

Fitch G, Williams K, Freeston JE, Dass S, Grainger A, Hodgson R, Horton L, Whitaker P, Peckham D. Fitch G, et al. J Cyst Fibros. 2016 Jul;15(4):e35-40. doi: 10.1016/j.jcf.2015.12.022. Epub 2016 Jan 20. J Cyst Fibros. 2016. PMID: 26809203 Free article.

51

Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols.

Fletcher LA, Chen Y, Whitaker P, Denton M, Peckham DG, Clifton IJ. Fletcher LA, et al. Among authors: peckham dg. Eur Respir J. 2016 Dec;48(6):1789-1791. doi: 10.1183/13993003.00849-2016. Epub 2016 Sep 22. Eur Respir J. 2016. PMID: 27660513 Free article. No abstract available.

52

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.

Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, L Whitehouse J, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW. Barr HL, et al. J Cyst Fibros. 2017 Mar;16(2):230-238. doi: 10.1016/j.jcf.2016.10.005. Epub 2016 Oct 20. J Cyst Fibros. 2017. PMID: 27773591 Free PMC article.

53

Detection of drug-responsive B lymphocytes and antidrug IgG in patients with β-lactam hypersensitivity.

Amali MO, Sullivan A, Jenkins RE, Farrell J, Meng X, Faulkner L, Whitaker P, Peckham D, Park BK, Naisbitt DJ. Amali MO, et al. Allergy. 2017 Jun;72(6):896-907. doi: 10.1111/all.13087. Epub 2016 Dec 8. Allergy. 2017. PMID: 27861994 Free article.

54

β-Lactam hypersensitivity involves expansion of circulating and skin-resident T_H22 cells.

Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, Park BK, Naisbitt DJ. Sullivan A, et al. J Allergy Clin Immunol. 2018 Jan;141(1):235-249.e8. doi: 10.1016/j.jaci.2017.01.020. Epub 2017 Feb 20. J Allergy Clin Immunol. 2018. PMID: 28219704

55

Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis.

White H, Shaw N, Denman S, Pollard K, Wynne S, Peckham DG. White H, et al. Among authors: peckham dg. Eur Respir J. 2017 Mar 8;49(3):1600987. doi: 10.1183/13993003.00987-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28275171 Free article.

56

A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.

Plant BJ, Downey DG, Eustace JA, Gunaratnam C, Haworth CS, Jones AM, McKone EF, Peckham DG, Ketchell RI, Bilton D. Plant BJ, et al. Among authors: peckham dg. J Cyst Fibros. 2017 Nov;16(6):695-701. doi: 10.1016/j.jcf.2017.02.006. Epub 2017 Apr 6. J Cyst Fibros. 2017. PMID: 28392014 Free article.

57

Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.

Meng X, Al-Attar Z, Yaseen FS, Jenkins R, Earnshaw C, Whitaker P, Peckham D, French NS, Naisbitt DJ, Park BK. Meng X, et al. J Immunol. 2017 Jun 1;198(11):4217-4227. doi: 10.4049/jimmunol.1700209. Epub 2017 Apr 24. J Immunol. 2017. PMID: 28438900 Free PMC article.

58

Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.

Amali MO, Jenkins RE, Meng X, Faulkner L, Whitaker P, Peckham D, Park BK, Naisbitt DJ. Amali MO, et al. Chem Res Toxicol. 2017 Dec 18;30(12):2097-2099. doi: 10.1021/acs.chemrestox.7b00291. Epub 2017 Nov 22. Chem Res Toxicol. 2017. PMID: 29148816

59

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis.

Sawant A, Spoletini G, Whitaker P, Etherington C, Clifton I, Peckham D. Sawant A, et al. ERJ Open Res. 2018 Jan 10;4(1):00111-2017. doi: 10.1183/23120541.00111-2017. eCollection 2018 Jan. ERJ Open Res. 2018. PMID: 29333432 Free PMC article.

60

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

Spoletini G, Kennedy M, Flint L, Graham T, Etherington C, Shaw N, Whitaker P, Denton M, Clifton I, Peckham D. Spoletini G, et al. Pulm Pharmacol Ther. 2018 Jun;50:82-87. doi: 10.1016/j.pupt.2018.04.007. Epub 2018 Apr 13. Pulm Pharmacol Ther. 2018. PMID: 29660401 Free article.

61

The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care.

Tsopra R, Peckham D, Beirne P, Rodger K, Callister M, White H, Jais JP, Ghosh D, Whitaker P, Clifton IJ, Wyatt JC. Tsopra R, et al. Int J Med Inform. 2018 Jul;115:35-42. doi: 10.1016/j.ijmedinf.2018.03.015. Epub 2018 Mar 27. Int J Med Inform. 2018. PMID: 29779718

62

Level of accuracy of diagnoses recorded in discharge summaries: A cohort study in three respiratory wards.

Tsopra R, Wyatt JC, Beirne P, Rodger K, Callister M, Ghosh D, Clifton IJ, Whitaker P, Peckham D. Tsopra R, et al. J Eval Clin Pract. 2019 Feb;25(1):36-43. doi: 10.1111/jep.13020. Epub 2018 Aug 14. J Eval Clin Pract. 2019. PMID: 30105889 Free article.

63

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.

Spoletini G, Etherington C, Shaw N, Clifton IJ, Denton M, Whitaker P, Peckham DG. Spoletini G, et al. Among authors: peckham dg. J Antimicrob Chemother. 2019 May 1;74(5):1425-1429. doi: 10.1093/jac/dky558. J Antimicrob Chemother. 2019. PMID: 30649419

64

Assessing arthritis in the context of cystic fibrosis.

Clarke EA, Watson P, Freeston JE, Peckham DG, Jones AM, Horsley A. Clarke EA, et al. Among authors: peckham dg. Pediatr Pulmonol. 2019 Jun;54(6):770-777. doi: 10.1002/ppul.24290. Epub 2019 Mar 5. Pediatr Pulmonol. 2019. PMID: 30838784 Review.

65

Cystic Fibrosis Diagnosis in Newborns, Children, and Adults.

Castellani C, Linnane B, Pranke I, Cresta F, Sermet-Gaudelus I, Peckham D. Castellani C, et al. Semin Respir Crit Care Med. 2019 Dec;40(6):701-714. doi: 10.1055/s-0039-1697961. Epub 2019 Nov 3. Semin Respir Crit Care Med. 2019. PMID: 31679154 Review.

66

Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis.

Jarosz-Griffiths HH, Scambler T, Wong CH, Lara-Reyna S, Holbrook J, Martinon F, Savic S, Whitaker P, Etherington C, Spoletini G, Clifton I, Mehta A, McDermott MF, Peckham D. Jarosz-Griffiths HH, et al. Elife. 2020 Mar 2;9:e54556. doi: 10.7554/eLife.54556. Elife. 2020. PMID: 32118580 Free PMC article.

67

Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations.

Lara-Reyna S, Holbrook J, Jarosz-Griffiths HH, Peckham D, McDermott MF. Lara-Reyna S, et al. Cell Mol Life Sci. 2020 Nov;77(22):4485-4503. doi: 10.1007/s00018-020-03540-9. Epub 2020 May 4. Cell Mol Life Sci. 2020. PMID: 32367193 Free PMC article. Review.

68

Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry.

Caley L, Smith L, White H, Peckham DG. Caley L, et al. Among authors: peckham dg. J Cyst Fibros. 2021 Jan;20(1):86-90. doi: 10.1016/j.jcf.2020.04.008. Epub 2020 May 5. J Cyst Fibros. 2021. PMID: 32381400 Free article.

69

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.

Lipman M, Cleverley J, Fardon T, Musaddaq B, Peckham D, van der Laan R, Whitaker P, White J. Lipman M, et al. BMJ Open Respir Res. 2020 Jun;7(1):e000591. doi: 10.1136/bmjresp-2020-000591. BMJ Open Respir Res. 2020. PMID: 32565445 Free PMC article. Review.

70

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.

McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.

71

Why is mock care not a good proxy for predicting hand contamination during patient care?

King MF, Wilson AM, López-García M, Proctor J, Peckham DG, Clifton IJ, Dancer SJ, Noakes CJ. King MF, et al. Among authors: peckham dg. J Hosp Infect. 2021 Mar;109:44-51. doi: 10.1016/j.jhin.2020.11.016. Epub 2020 Nov 30. J Hosp Infect. 2021. PMID: 33271214 Free article.

72

Smartphone pedometers in adults with asthma: a practical approach to physical activity assessment? A pilot validation study.

Reilly C, Stavropoulos-Kalinoglou A, Clifton I, McKenna J, Peckham D, Price OJ. Reilly C, et al. J Asthma. 2022 May;59(5):967-975. doi: 10.1080/02770903.2021.1882487. Epub 2021 Feb 13. J Asthma. 2022. PMID: 33504229 Free article.

73

Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial.

Spoletini G, Watson R, Lim WY, Pollard K, Etherington C, Clifton IJ, Peckham DG. Spoletini G, et al. Among authors: peckham dg. J Cyst Fibros. 2021 Sep;20(5):e46-e52. doi: 10.1016/j.jcf.2021.03.005. Epub 2021 Apr 1. J Cyst Fibros. 2021. PMID: 33814320 Free article. Clinical Trial.

74

Cystic fibrosis-related diabetes (CFRD) and cognitive function in adults with cystic fibrosis.

Chadwick HK, Abbott J, Hurley MA, Dye L, Lawton CL, Mansfield MW, Peckham D. Chadwick HK, et al. J Cyst Fibros. 2022 May;21(3):519-528. doi: 10.1016/j.jcf.2021.04.014. Epub 2021 Jun 14. J Cyst Fibros. 2022. PMID: 34134937 Free article.

75

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.

Archangelidi O, Cullinan P, Simmonds NJ, Mentzakis E, Peckham D, Bilton D, Carr SB. Archangelidi O, et al. J Cyst Fibros. 2022 Mar;21(2):302-308. doi: 10.1016/j.jcf.2021.07.004. Epub 2021 Aug 1. J Cyst Fibros. 2022. PMID: 34348871 Free article.

76

Nutritional status and intake in patients with non-cystic fibrosis bronchiectasis (NCFB) - a cross sectional study.

King L, White H, Clifton I, Spoletini G, Ispoglou T, Peckham DG. King L, et al. Among authors: peckham dg. Clin Nutr. 2021 Sep;40(9):5162-5168. doi: 10.1016/j.clnu.2021.07.032. Epub 2021 Aug 8. Clin Nutr. 2021. PMID: 34461590

77

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.

Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, Van Braeckel E, Wainwright CE, Watson D, Ahluwalia N, Bruinsma BG, Harris C, Lam AP, Lou Y, Moskowitz SM, Tian S, Yuan J, Waltz D, Mall MA; VX18-445-109 study group. Sutharsan S, et al. Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20. Lancet Respir Med. 2022. PMID: 34942085 Clinical Trial.

78

Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis.

Spoletini G, Fitch G, Gillgrass L, Etherington C, Clifton I, Peckham DG. Spoletini G, et al. Among authors: peckham dg. ERJ Open Res. 2022 May 9;8(2):00669-2021. doi: 10.1183/23120541.00669-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35539439 Free PMC article.

79

Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis.

Spoletini G, Gillgrass L, Pollard K, Shaw N, Williams E, Etherington C, Clifton IJ, Peckham DG. Spoletini G, et al. Among authors: peckham dg. J Cyst Fibros. 2022 Nov;21(6):1061-1065. doi: 10.1016/j.jcf.2022.05.001. Epub 2022 May 16. J Cyst Fibros. 2022. PMID: 35585012 Free article.

80

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.

81

Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients.

Ariza A, Jaruthamsophon K, Meng X, Labella M, Adair K, Tailor A, Sukasem C, Whitaker P, Peckham D, Pirmohamed M, Torres MJ, Naisbitt DJ. Ariza A, et al. Chem Res Toxicol. 2022 Nov 21;35(11):2122-2132. doi: 10.1021/acs.chemrestox.2c00231. Epub 2022 Sep 22. Chem Res Toxicol. 2022. PMID: 36137197 Free PMC article.

82

Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis.

Peckham D, Spoletini G. Peckham D, et al. Semin Respir Crit Care Med. 2023 Apr;44(2):217-224. doi: 10.1055/s-0042-1758730. Epub 2022 Dec 19. Semin Respir Crit Care Med. 2023. PMID: 36535666

83

Role of inhaled antibiotics in the era of highly effective CFTR modulators.

Elborn JS, Blasi F, Burgel PR, Peckham D. Elborn JS, et al. Eur Respir Rev. 2023 Jan 11;32(167):220154. doi: 10.1183/16000617.0154-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36631132 Free PMC article. Review.

84

Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis.

Reilly C, Sails J, Stavropoulos-Kalinoglou A, Birch RJ, McKenna J, Clifton IJ, Peckham D, Birch KM, Price OJ. Reilly C, et al. Eur Respir Rev. 2023 Jan 25;32(167):220109. doi: 10.1183/16000617.0109-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36697208 Free PMC article. Review.

85

Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant.

Tachtatzis P, Spoletini G, Clifton I, Etherington C, Peckham D. Tachtatzis P, et al. J Cyst Fibros. 2024 Jan;23(1):99-102. doi: 10.1016/j.jcf.2023.04.023. Epub 2023 May 8. J Cyst Fibros. 2024. PMID: 37164896

86

Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia.

Peckham D, Crouch S, Humphreys H, Lobo B, Tse A, Knox AJ. Peckham D, et al. Thorax. 1994 Aug;49(8):803-7. doi: 10.1136/thx.49.8.803. Thorax. 1994. PMID: 7522353 Free PMC article.

87

Na+ in cystic fibrosis: is it important?

Knox A, Peckham D. Knox A, et al. Trends Pharmacol Sci. 1995 Apr;16(4):120-1. doi: 10.1016/s0165-6147(00)88997-x. Trends Pharmacol Sci. 1995. PMID: 7610495 No abstract available.

88

Resolution of superior vena cava obstruction following thrombolytic therapy in a patient with cystic fibrosis and a long-term indwelling catheter.

Peckham DG, Hill J, Manhire AR, Knox AJ. Peckham DG, et al. Respir Med. 1994 Sep;88(8):627-9. doi: 10.1016/s0954-6111(05)80012-5. Respir Med. 1994. PMID: 7991889 No abstract available.

89

Cystic fibrosis presenting as acute pancreatitis and obstructive azoospermia in a young adult male with a novel mutation in the CFTR gene.

Conway SP, Peckham DG, Chu CE, Ellis LA, Ahmed M, Taylor GR. Conway SP, et al. Among authors: peckham dg. Pediatr Pulmonol. 2002 Dec;34(6):491-5. doi: 10.1002/ppul.10190. Pediatr Pulmonol. 2002. PMID: 12422349

90

Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study.

Conway SP, Oldroyd B, Morton A, Truscott JG, Peckham DG. Conway SP, et al. Among authors: peckham dg. Thorax. 2004 Aug;59(8):699-703. doi: 10.1136/thx.2002.002568. Thorax. 2004. PMID: 15282392 Free PMC article.

91

Dietary intakes in adult patients with cystic fibrosis--do they achieve guidelines?

White H, Morton AM, Peckham DG, Conway SP. White H, et al. Among authors: peckham dg. J Cyst Fibros. 2004 Mar;3(1):1-7. doi: 10.1016/j.jcf.2003.12.002. J Cyst Fibros. 2004. PMID: 15463880 Free article.

92

Azithromycin in cystic fibrosis.

Kastelik JA, Peckham DG, Conway S. Kastelik JA, et al. Among authors: peckham dg. Eur Respir J. 2005 Apr;25(4):771; author reply 771-2. doi: 10.1183/09031936.05.00129304. Eur Respir J. 2005. PMID: 15802355 Free article. No abstract available.

93

Establishing a diagnosis of cystic fibrosis.

Southern KW, Peckham D. Southern KW, et al. Chron Respir Dis. 2004;1(4):205-10. doi: 10.1191/1479972304cd044rs. Chron Respir Dis. 2004. PMID: 16281647 Free article. Review.

94

Respiratory exacerbations in childhood associated with compound heterozygosity Phe508del/Arg117His-7T of the cystic fibrosis transmembrane regulator gene.

Lee TW, Conway SP, Peckham D, Brownlee KG. Lee TW, et al. Acta Paediatr. 2008 May;97(5):670-2. doi: 10.1111/j.1651-2227.2008.00716.x. Acta Paediatr. 2008. PMID: 18394117

95

Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

Barton RC, Hobson RP, Denton M, Peckham D, Brownlee K, Conway S, Kerr MA. Barton RC, et al. Diagn Microbiol Infect Dis. 2008 Nov;62(3):287-91. doi: 10.1016/j.diagmicrobio.2008.06.018. Diagn Microbiol Infect Dis. 2008. PMID: 18947811

96

Routine screening for cystic fibrosis-related diabetes.

Peckham D. Peckham D. J R Soc Med. 2009 Jul;102 Suppl 1(Suppl 1):36-9. doi: 10.1258/jrsm.2009.s19008. J R Soc Med. 2009. PMID: 19605873 Free PMC article. Review. No abstract available.

97

Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis.

Barton RC, Borman AM, Johnson EM, Houbraken J, Hobson RP, Denton M, Conway SP, Brownlee KG, Peckham D, Lee TW. Barton RC, et al. J Clin Microbiol. 2010 Jul;48(7):2615-7. doi: 10.1128/JCM.00184-10. Epub 2010 Apr 26. J Clin Microbiol. 2010. PMID: 20421435 Free PMC article.

98

Cystic fibrosis co-existing with trisomy 21.

Guy EL, Peckham DG, Brownlee KG, Conway SP, Lee TW. Guy EL, et al. Among authors: peckham dg. J Cyst Fibros. 2010 Sep;9(5):330-1. doi: 10.1016/j.jcf.2010.05.003. Epub 2010 Jun 11. J Cyst Fibros. 2010. PMID: 20538528 Free article.

99

Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information.

Wright KF, Bryant LD, Morley S, Hewison J, Duff AJ, Peckham D. Wright KF, et al. Health Expect. 2015 Oct;18(5):1349-62. doi: 10.1111/hex.12113. Epub 2013 Aug 2. Health Expect. 2015. PMID: 23910894 Free PMC article.

100

European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre.

Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T, Heijerman H, Lannefors L, Lindblad A, Macek M, Madge S, Moran M, Morrison L, Morton A, Noordhoek J, Sands D, Vertommen A, Peckham D. Conway S, et al. J Cyst Fibros. 2014 May;13 Suppl 1:S3-22. doi: 10.1016/j.jcf.2014.03.009. J Cyst Fibros. 2014. PMID: 24856776 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page